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Reepithelialization and granulation tissue formation
during cutaneous wound repair are mediated by a
wide variety of growth and differentiation factors.
Recent studies from our laboratory provided evid-
ence for an important role of keratinocyte growth
factor (KGF) in the repair of the injured epithelium
and for a novel function of the transforming growth
factor-b superfamily member activin in granulation
tissue formation. KGF is weakly expressed in human
skin, but is strongly upregulated in dermal ®broblasts
after skin injury. Its binding to a transmembrane
receptor on keratinocytes induces proliferation and
migration of these cells. Furthermore, KGF has been
shown to protect epithelial cells from the toxic
effects of reactive oxygen species. We have identi®ed
a series of KGF-regulated genes that are likely to
play a role in these processes. In addition to KGF,
activin seems to be a novel player in wound healing.
Activin expression is hardly detectable in nonwounded
skin, but this factor is highly expressed in redifferen-
tiating keratinocytes of the hyperproliferative wound
epithelium as well as in cells of the granulation tissue.
To gain insight into the role of activin in wound
repair, we generated transgenic mice that overexpress
activin in basal keratinocytes of the epidermis. These
mice were characterized by a hyperthickened epider-
mis and by dermal ®brosis. Most importantly, over-
expression of activin strongly enhanced the process of
granulation tissue formation, demonstrating a novel
and important role of activin in cutaneous wound
repair. Key words: epidermis/®broblast growth factor/perox-
idase. Journal of Investigative Dermatology Symposium
Proceedings 5:34±39, 2000
C
utaneous injury initiates a series of events including
in¯ammation, reepithelialization, and granulation
tissue formation, and ®nally matrix remodeling.
These processes are controlled by a multitude of
cell±cell and cell±matrix interactions, but also by
various growth and differentiation factors (reviewed by Martin,
1997). Although expression of many of these factors has been
described in the healing wound, their precise roles and mechanisms
of action have been poorly de®ned. Members of the ®broblast
growth factor (FGF) and transforming growth factor (TGF)-b
families have been shown to be key players in this process. Thus
recent studies from our laboratory demonstrated an important role
of keratinocyte growth factor (KGF, FGF-7) and its receptor in the
repair of the injured epithelium, as well as a dual role of the TGF-b
superfamily member activin in keratinocyte differentiation and
particularly in granulation tissue formation. Here we report on the
expression and function of these growth and differentiation factors
in normal skin and particularly during cutaneous wound repair.
KERATINOCYTE GROWTH FACTOR
KGF was initially discovered by Rubin et al (1989) as a lung
®broblast-derived mitogen for mouse keratinocytes. It is a
monomeric glycoprotein of 26±28 kDa that is produced by various
types of mesenchymal cells in vitro and in vivo (reviewed by Werner,
1998) as well as by gd T cells obtained from skin and intestine
(Boismenu and Havran, 1994). KGF expression has as yet not been
detected in cells of epithelial origin; however, most types of
epithelial cells express FGFR2-IIIb, the only known high-af®nity
receptor for KGF (Miki et al, 1991), and these cells were shown to
respond to KGF in vitro and in vivo (for review see Werner, 1998).
These results suggested that KGF acts predominantly in a paracrine
manner. Such a paracrine action of KGF seems to occur in normal
and particularly in wounded skin. We and others demonstrated a
weak expression of KGF in murine and human skin; however,
expression of this mitogen was strikingly induced in dermal
®broblasts upon skin injury (Werner et al, 1992; Marchese et al,
1995). By contrast, the KGF receptor was exclusively expressed on
keratinocytes of the epidermis and the hair follicles. This expression
pattern of KGF and its receptor suggested that dermally derived
KGF stimulates wound reepithelialization in a paracrine manner.
This hypothesis was strongly supported by the wound healing
phenotype seen in transgenic mice, which express a dominant-
negative KGF receptor in the basal keratinocytes of the epidermis
and in the outer root sheath keratinocytes of the hair follicles.
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These mice were characterized by a severe delay in wound
reepithelialization (Werner et al, 1994), demonstrating the
importance of KGF receptor signaling during cutaneous wound
repair. Surprisingly, mice lacking KGF revealed no phenotypic
abnormalities and even the healing process of incisional wounds
appeared normal (Guo et al, 1996), suggesting that other KGF
receptor ligands can compensate for the lack of KGF. The most
likely candidate for such a compensatory effect is FGF-10, which is
highly homologous to KGF (Yamasaki et al, 1996) and which binds
to the KGF receptor with high af®nity (Igarashi et al, 1998). As
shown in Fig 1, a very similar expression pattern of KGF (FGF-7)
and FGF-10 was observed in adult mouse tissues, whereby both
factors were expressed at particularly high levels in the lung and the
skin. Interestingly, they are coexpressed with their only high-
af®nity receptor (FGFR2-IIIb) in these tissues (Fig 1, lower panel),
indicating that their strong expression is functionally important.
These data suggest that FGF-10 can indeed compensate for the lack
of FGF-7 in a knockout mouse. We also found expression of FGF-
10 in wounded skin, although it was not upregulated at the
transcriptional level; however, the levels of bioactive FGF-10 in the
skin might be increased by wounding, as FGF-10 was shown to be
cell associated in vitro and thus might be released from the cells
upon injury (Beer et al, 1997). In summary, these results
demonstrated an important role of KGF receptor ligands in wound
repair, although the precise function of each ligand in this process
remains to be determined.
To gain insight into the mechanisms of KGF and FGF-10 action
in normal and wounded skin we searched for genes that are
regulated by these factors in cultured keratinocytes. For this
purpose we used the differential display reverse transcriptase-
polymerase chain reaction technology and we also generated a
subtractive cDNA library from quiescent and KGF-treated
keratinocytes. Using these technologies we identi®ed a wide
variety of KGF-regulated genes. Besides several unknown genes we
also identi®ed various known genes that are summarized in Fig 2.
These genes might help to explain how KGF mediates various
processes in normal and wounded skin, such as keratinocyte
proliferation and migration, protection from the toxic effects of
reactive oxygen species, and indirect effects such as angiogenesis
and stimulation of matrix deposition. The KGF-regulated genes
and their possible functions in normal and wounded skin are
described below.
Genes that are involved in the regulation of keratinocyte
proliferation and migration Various genes were identi®ed that
are likely to be involved in the mitogenic effect of KGF. One of the
genes encodes adenylosuccinate lyase, an enzyme involved in
purine de novo synthesis and in the salvage pathway (Gassmann et al,
1999). To determine whether regulation of enzymes involved in
nucleotide biosynthesis is a general mechanism of KGF action, we
cloned cDNA probes of the key regulatory enzymes involved in
this metabolic pathway, including adenylosuccinate synthetase, the
enzyme responsible for converting inosine monophosphate into
adenylosuccinate; phosphoribosyl pyrophosphate synthetase, which
generates phosphoribosyl pyrophosphate, a molecule required for
de novo production of both purine and pyrimidine nucleotides and
for the purine salvage pathway; amidophosphoribosyl transferase, a
key regulatory enzyme in purine biosynthesis; hypoxanthine
(guanine) phosphoribosyl transferase (HPRT), an important
enzyme of the salvage pathway, and of the multifunctional
protein CAD (carbamoylphosphate synthetase II, aspartate
transcarbamylase, dihydroorotase). Interestingly, the expression of
all of these enzymes was strongly induced by KGF in cultured
keratinocytes, as shown in Fig 3(A) for HPRT. This regulation is
Figure 1. Expression of KGF (FGF-7), FGF-10, and FGFR2-IIIb
(KGF receptor) in adult mouse tissues. Total cellular RNA was
isolated from adult mouse tissues; 20 mg RNA was analyzed for the
expression of KGF (FGF-7), FGF-10, and FGFR2-IIIb by RNase
protection assay; 20 mg tRNA were used as a negative control; 1000 cpm
of the hybridization probes were loaded in the lanes labeled ``probe'' and
used as a size marker. The same set of RNA was used for all protection
assays. Reprinted from Beer et al (1997) and from Beer et al (J Biol Chem
275:16091±16097, 2000) with permission from Stockton Press and from
the American Society for Biochemistry of Molecular Biology.
Figure 2.Overview of KGF-regulated genes.
The products of the genes shown on the right-
hand side are likely to mediate the direct effects of
KGF, whereas those on the left-hand side could
be responsible for the indirect effects of KGF on
mesenchymal cells.
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likely to be important for the in vivo situation, because we found
high levels of the corresponding transcripts in healing skin wounds
(Fig 3B), particularly in the KGF-responsive keratinocytes of the
hyperproliferative epithelium at the wound edge (Gassmann et al,
1999; Fig 3C). These ®ndings suggest that KGF also stimulates the
synthesis of enzymes involved in nucleotide biosynthesis during
wound healing, which should allow the production of suf®cient
amounts of nucleotides required for DNA replication and RNA
synthesis.
In addition to these nucleotide biosynthesis enzymes, we
recently identi®ed a putative human homolog of the yeast
CHL-1 gene as a KGF-regulated gene (Frank and Werner,
1996). In the yeast, this gene is involved in the regulation of
chromosome segregation and cell cycle progression (Gerring et al,
1990), suggesting that a human homolog might have a similar
function in keratinocytes. Finally, we found upregulation of the
transcription factor c-myc in response to KGF and downregulation
of a putative novel transcription factor (KRG-3, KGF-regulated
gene 3) (H.-D.B., unpublished data). Preliminary results from our
laboratory suggest a role of the latter in the regulation of
keratinocyte differentiation, indicating that downregulation of a
differentiation-inducing factor might play a role in the mitogenic
effect of KGF.
With regard to the stimulatory effect of KGF on keratinocyte
migration, we found a KGF-mediated increase in the expression of
the matrix metalloproteinase stromelysin-2 (Madlener et al, 1996).
The latter is normally expressed in migrating keratinocytes at the
wound edge where it is likely to be responsible for the degradation
of the provisional matrix, a function that is essential for migration of
keratinocytes into the wound (reviewed by Parks and Sires, 1996).
Genes that mediate the protective effect of KGF An
important feature of KGF is its protective effect for various types
of epithelial cells. Thus, recombinant KGF was successfully used as
a pretreatment in several mouse models of gastrointestinal injury
induced by radiation, chemotherapy, or a combination of both. In
the bladder, injection of KGF before cyclophosphamide prevented
the ulcerative hemorrhagic cystitis that is normally induced by this
drug, and in the lung, exogenous KGF prevented lung injury in
various model systems (reviewed by Werner, 1998). Finally, recent
Figure 3. Increased expression of HPRT by KGF in vitro and by
cutaneous injury in vivo. (A) KGF-regulated expression of HPRT in
HaCaT keratinocytes. Quiescent HaCaT keratinoytes were incubated with
KGF for different time periods as indicated; 20 mg total cellular RNA were
analyzed for the expression of HPRT; 20 mg tRNA were used as a negative
control; 1000 cpm of the different hybridization probe was loaded in the
lane labeled ``probe'' and used as a size marker. (B) Expression of HPRT
during cutaneous wound repair in mice. Full-thickness excisional wounds
were generated on the back of BALB/C mice. Mice were sacri®ced at
different time points after injury. The complete wounds were isolated and
used for RNA isolation; 20 mg total cellular RNA from normal and
wounded skin were analyzed by RNase protection assay for the expression
of HPRT; 20 mg tRNA were used as a negative control; 1000 cpm of the
hybridization probe was loaded in the lane labeled ``probe'' and used as a
size marker. (C) Expression of HPRT in 5 day full-thickness excisional
wounds. Frozen sections from the middle of full-thickness excisional
wounds were hybridized with a 35S-labeled antisense riboprobe comple-
mentary to the murine HPRT. Scale bar: 1 mm. Signals appear as white dots
in the dark ®eld survey. ES, Eschar; HE, hyperproliferative epithelium; G,
granulation tissue. The ®gure has been adopted from Gassmann et al (1999),
with permission from Stockton Press.
Figure 4. Effect of KGF on the expression of enzymes involved in
the detoxi®cation of reactive oxygen species. Quiescent HaCaT
keratinocytes were treated with KGF for different time periods as indicated;
20 mg RNA isolated from these cells were analyzed by RNase protection
assay for the expression of the nonselenium glutathione peroxidase
(nsGPx), the phospholipid hydroperoxide glutathione peroxidase (PhGPx),
catalase (CAT), the Mn-dependent superoxide dismutase (Mn-SOD), and
the Cu/Zn-dependent superoxide dismutase (Cu/Zn-SOD); 20 mg tRNA
were used as a negative control; 1000 cpm of the hybridization probes were
loaded in the lanes labeled ``probe'' and used as a size marker. The same set
of RNA was used for all protection assays. The RNase protection assay
showing nsGPx expression was adopted from Frank et al (1997), with
permission from Stockton Press.
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results from our laboratory suggest that KGF can reduce oxidative
damage in keratinocytes. These observations suggested that KGF
can induce the expression of enzymes involved in the
detoxi®cation of reactive oxygen species. To test this possibility,
we analyzed the effect of KGF on the expression of phospholipid
hydroperoxide glutathione peroxidase, as well as catalase and the
Mn-and Cu/Zn-dependent superoxide dismutases. As shown in
Fig 4, none of these enzymes was regulated by KGF at the
transcriptional level. We identi®ed a nonselenium glutathione
peroxidase, however, as a novel KGF-regulated gene using the
differential display reverse transcriptase-polymerase chain reaction
technology (Frank et al, 1997). Expression of this enzyme was only
induced by KGF but not by other growth factors in keratinocytes,
suggesting that this effect is speci®c for KGF. The upregulation of
this enzyme by KGF is likely to be important in vivo, because the
enzyme was strongly overexpressed in the hyperproliferative
epithelium of murine skin wounds (Munz et al, 1997) and of
psoriatic human skin (Frank et al, 1997) where KGF is strongly
expressed (Werner et al, 1992; Finch et al, 1997). These results
suggested that KGF reduces the toxic effects of reactive oxygen
species at least in part by upregulation of this enzyme. In addition,
we recently demonstrated increased expression of DNA repair
enzymes by KGF in vitro, demonstrating that KGF regulates various
genes that protect epithelial cells from environmental damage.
Genes that mediate indirect effects of KGF In addition to its
direct effects on keratinocytes, studies by Staiano-Coico et al (1993)
and Jimenez and Rampy (1999) demonstrated indirect effects of
exogenously applied KGF or FGF-10, respectively, on the
granulation tissue. Thereby, increased collagen deposition was
observed in both studies. Because KGF is likely to act only on
epithelial cells in the wound, the observed stimulation of
granulation tissue formation might be a result of other factors
that are upregulated by KGF in keratinocytes. Indeed, we
previously demonstrated a striking upregulation of vascular
endothelial growth factor expression by KGF in cultured HaCaT
keratinocytes (Frank et al, 1995), suggesting that KGF can indirectly
stimulate angiogenesis via VEGF induction. Furthermore, we
recently demonstrated induction of TGF-b1 and activin expression
by KGF in cultured keratinocytes (HuÈbner and Werner, 1996;
Frank and Werner, unpublished data). Because both of these factors
stimulate production of extracellular matrix molecules in ®broblasts
in vitro and in vivo (reviewed by Roberts and Sporn, 1996;
Sugiyama et al, 1998; Munz et al, 1999a; see below), they might be
at least partially responsible for the increased collagen deposition
seen in KGF-treated wounds. The potent stimulation of activin
expression by KGF in keratinocytes tempted us to speculate about a
novel role of activin in wound repair. Indeed, this hypothesis has
recently been con®rmed, and the results that we have obtained
with activin will be summarized below.
ACTIVIN
Activins, which belong to the TGF-b superfamily of growth and
differentiation factors, are dimeric proteins, the monomeric poly-
peptides of which are connected by disul®de linkage. Three different
forms of activin, activin A (bAbA), activin B (bBbB), and activin AB
(bAbB), have been characterized (reviewed by MassagueÂ, 1990; Vale
et al, 1990). Furthermore, bC, bD, and bE chains have been
discovered (HoÈtten et al, 1995; Oda et al, 1995; Fang et al, 1996),
although the function of the corresponding proteins is as yet
unknown. Activins in¯uence proliferation and differentiation of
many different cell types (reviewed by Vale et al, 1990), but a role of
activin in normal and wounded skin has only recently been
demonstrated. The ®rst evidence for a possible role of activin in the
skin resulted from the phenotypes of knockout mice. Besides various
defects that caused death within the ®rst 24 h after birth, activin bA
knockout mice lacked whiskers and whisker follicles were abnormal
(Matzuk et al, 1995a), and mice de®cient in the soluble activin binding
protein follistatin showed disturbed whisker development and
hyperkeratotic skin (Matzuk et al, 1995b).
Increased expression of activin after skin injury To gain
insight into the function of activin in normal and wounded skin,
we recently analyzed the expression of activin and its receptors
during cutaneous wound repair in mice. Activin expression was
hardly detectable in nonwounded back skin; however, we found a
strikingly increased expression of activin bA and bB mRNA in the
granulation tissue and in suprabasal keratinocytes of the hyper-
proliferative epithelium after skin injury (HuÈbner et al, 1996).
Furthermore, all known activin receptors were expressed in the
mesenchymal and epithelial compartments of normal and wounded
skin, although their expression did not change after injury (HuÈbner
et al, 1996). These results suggested a dual function of activin in the
granulation tissue and also in the differentiating keratinocytes.
Overexpression of activin in the epidermis of transgenic
mice causes epidermal thickening, dermal ®brosis, and
enhanced wound repair (Munz et al, 1999a) To determine
the activities of activin in the skin, we overexpressed the activin bA
chain in the epidermis of transgenic mice under the control of a
keratin 14 promoter that targets the expression of transgenes to the
Figure 5. Expression of the basal keratin 14 in
the tail skin of normal and activin-over-
expressing mice. Six micrometer frozen sections
were stained with a monospeci®c antiserum direc-
ted against keratin 14 and a rhodamine-coupled
secondary antibody. Note the severe hyper-
thickening of the epidermis of the transgenic mice
(A) and the strong expression of keratin 14 in
basal cells of the epidermis as well as in outer root
sheath keratinocytes of the hair follicles of normal
(B) and activin-overexpressing mice (A).
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nondifferentiated basal cells of the epidermis and to the
keratinocytes of the outer root sheath of the hair follicles (Vassar
et al, 1989; Ongena and Huylebroeck, unpublished data). The
transgenic mice revealed signi®cant abnormalities in the skin. The
epidermis was much thicker compared with the skin of control
animals (Fig 5B). The spinous layer was greatly increased compared
with normal epidermis, but little parakeratosis was observed in the
corni®ed layer. Furthermore, the epidermal architecture was highly
disorganized. Consistent with the appearance of the epidermis, the
rate of proliferating basal keratinocytes was 2.5-fold higher in the
skin of transgenic animals compared with the controls. This
stimulation of keratinocyte proliferation by activin is likely to be
indirect, as activin inhibited proliferation of human HaCaT
keratinocytes (Shimizu et al, 1998) and primary keratinocytes
in vitro (Seishimi et al, 1999).
We subsequently determined the stage of differentiation of the
additional nucleated suprabasal cells. Interestingly, the basal cell
keratin 14 (Fig 5) and the differentiation-speci®c keratin 10 were
expressed in the appropriate layers in normal and transgenic mice,
demonstrating that the additional layers seen in the epidermis of the
transgenic animals consist of at least partially differentiated cells. These
cells did not express markers of terminal differentiation, however,
indicating that activin allows or even stimulates the early differentia-
tion process, whereas terminal differentiation seems to be delayed. A
role of activin in the early induction of keratinocyte differentiation is
further supported by the expression of activin in the suprabasal but not
in the basal cells of the hyperproliferative wound epithelium (HuÈbner
et al, 1996 and unpublished data). Induction of keratinocyte
differentiation by activin A has also been shown in primary
keratinocytes in vitro (Seishima et al, 1999). In contrast to our in vivo
results, however, the process of terminal differentiation was also
enhanced by activin in these cells. These discrepancies could be due to
the presence of other factors present in vivo in a hyperproliferative
epithelium that delay the later differentiation steps.
Apart from epidermal changes, the subcutaneous fatty tissue was
replaced by connective tissue in the transgenic mice. Therefore, we
analyzed the expression of various extracellular matrix proteins in
these animals. Although no signi®cant differences in the mRNA
expression levels of ®bronectin, collagen bI, collagen bIII, and of
the basement membrane proteins tenascin-C and nidogen were
observed, we found a strong deposition of tenascin-C in the
interfollicular dermis of the transgenic animals, whereas this protein
is normally restricted to the basement membrane zones. These
results suggest that activin gradually alters extracellular matrix
molecule metabolism, probably by diffusion from the keratinocytes
into the underlying dermis.
Finally, we generated full-thickness excisional wounds on the back
of transgenic mice and control litter mates, and we performed a
detailed histologic analysis of 5 day wounds from three independent
transgenic mouse lines that express high levels of the transgene.
Interestingly, the wound healing process in the activin-overexpres-
sing mice was strongly enhanced, whereby granulation tissue
formation was particularly stimulated. Large amounts of extracellular
matrix were detected below the activin-producing keratinocytes,
indicating that activin stimulates connective tissue synthesis/deposi-
tion not only in normal but also in wounded skin. These data suggest a
novel role of activin in®brotic processes and this hypothesis is strongly
supported by the detection of high activin levels in various types of
®brotic disease (reviewed by Munz et al, 1999b).
Taken together, our results provide ®rst evidence for an
important role of activin in wound repair as well as in keratinocyte
differentiation, in dermal ®brosis, and possibly also in human skin
disease.
We thank Andreas Stanzel and CeÂline Mamie for excellent technical assistance.
Work in our laboratory is supported by a Human Frontier Science Grant, the
German Ministry for Education and Research, and the Stiftung Verum.
REFERENCES
Beer H-D, Florence C, Dammeier J, McGuire L, Werner S, Duan DR: Mouse
®broblast growth factor 10: cDNA cloning, protein characterization, and
regulation of mRNA expression. Oncogene 15:2211±2218, 1997
Boismenu R, Havran WL: Modulation of epithelial cell growth by intraepithelial gdT
cells. Science 266:1253±1255, 1994
Fang JM, Yin WS, Smiley E, Wang SQ, Bonadio J: Molecular cloning of the mouse
activin beta (e) subunit gene. Biochem Biophys Res Commun 228:669±674,
1996
Finch PW, Murphy F, Cardinale I, Krueger JG: Altered expression of
keratinocyte growth factor and its receptor in psoriasis. Am J Pathol
149:521±529, 1997
Frank S, HuÈbner G, Breier G, Longaker MT, Greenhalgh DG, Werner S:
Regulation of vascular endothelial growth factor expression in cultured
keratinocytes: Implications for normal and impaired wound healing. J Biol
Chem 270:12607±12613, 1995
Frank S, Werner S: The human homologue of the yeast CHL1 gene is a novel
keratinocyte growth factor-regulated gene. J Biol Chem 271:24337±24340,
1996
Frank S, Munz B, Werner S: The human homologue of a bovine non-selenium
glutathione peroxidase is a novel keratinocyte growth factor-regulated gene.
Oncogene 14:915±921, 1997
Gassmann M, Stanzel A, Werner S: Growth factor ± regulated expression of enzymes
involved in nucleotide biosynthesis: a novel mechanism of growth factor
action. Oncogene 18:6667±6676, 1999
Gerring SL, Spencer F, Hieter P: The CHL1 (CTF1) gene product of Saccharomyces
cerevisiae is important for chromosome transmission and normal cell cycle
progression in G2/M. EMBO J 9:4347±4358, 1990
Guo L, Degenstein L, Fuchs E: Keratinocyte growth factor is required for hair
development but not for wound healing. Genes Dev 10:165±175, 1996
HoÈtten G, Neidhardt H, Schneider C, Pohl J: Cloning of a new member of the
TGF-b family: a putative new activin bC chain. Biochem Biophys Res Commun
106:608±613, 1995
HuÈbner G, Werner S: Serum growth factors and proin¯ammatory cytokines are
potent inducers of activin expression in cultured ®broblasts and keratinocytes.
Exp Cell Res 228:106±113, 1996
HuÈbner G, Hu Q, Smola H, Werner S: Strong induction of activin expression after
injury suggests an important role of activin in wound repair. Dev Biol 173:490±
498, 1996
Igarashi M, Finch PW, Aaronson SA: Characterization of recombinant human
®broblast growth factor (FGF)-10 reveals functional similarities with
keratinocyte growth factor (FGF-7). J Biol Chem 21:13230±13235, 1998
Jimenez P, Rampy MA: Keratinocyte growth factor-2 accelerates wound healing in
incisional wounds. J Surg Res 81:238±242, 1999
Madlener M, Mauch C, Conca W, Parks WC, Werner S: Regulation of the
expression of stromelysin-2 by growth factors in keratinocytes: implications for
normal and impaired wound healing. Biochem J 320:659±664, 1996
Marchese C, Chedid M, Dirsch OR, et al: Modulation of keratinocyte growth factor
and its receptor in reepithelializing human skin. J Exp Med 182:1369±1376,
1995
Martin P: Wound healing: aiming for perfect skin regeneration. Science 276:75±81,
1997
MassagueÂ J: The transforming growth factor-b family. Annu Rev Cell Biochem 6:597±
641, 1990
Matzuk MM, Kumar TR, Vassalli A, Bickenbach JR, Roop DR, Jaenisch R, Bradley
A: Functional analysis of activins during mammalian development. Nature
374:354±356, 1995a
Matzuk MM, Lu N, Vogel H, Sellheyer K, Roop DR, Bradley A: Multiple defects
and perinatal death in mice de®cient in follistatin. Nature 374:360±363,
1995b
Miki T, Fleming TP, Bottaro DP, Rubin JS, Ron D, Aaronson SA: Expression
cDNA cloning of the KGF receptor by creation of a transforming autocrine
loop. Science 251:72±75, 1991
Munz B, Frank S, HuÈbner G, Olsen E, Werner S: A novel type of glutathione
peroxidase: expression and regulation during wound repair. Biochem J 326:579±
585, 1997
Munz B, Smola H, Engelhardt F, et al: Overexpression of activin in the skin of
transgenic mice reveals new activities of activin in epidermal morphogenesis,
dermal ®brosis and wound repair. EMBO J 18:5205±5215, 1999a
Munz B, HuÈbner G, Tretter Y, Alzheimer C, Werner S: A novel role of activin in
in¯ammation and repair. J Endocrinol 161:187±193, 1999b
Oda S, Nishimatsu S-I, Murakami K, Ueno N: Molecular cloning and functional
analysis of a new activin b subunit: a dorsal mesoderm-inducing activity in
Xenopus. Biochem Biophys Res Commun 210:581±588, 1995
Parks WC, Sires UI: Matrix metalloproteinases in skin biology and disease. Curr Opin
Dermatol 3:240±247, 1996
Roberts AB, Sporn MB. Transforming growth factor-b. In: Clark RAF, ed. The
Molecular and Cellular Biology of Wound Repair, 2nd edn. New York: Plenum,
1996, pp. 275±308
Rubin JS, Osada DP, Finch PW, Taylor WG, Rudikoff S, Aaronson SA: Puri®cation
and characterization of a newly identi®ed growth factor speci®c for epithelial
cells. Proc Natl Acad Sci USA 86:802±806, 1989
Seishima M, Nojiri M, Esaki C, Yoneda K, Eto Y, Kitajima Y: Activin A induces
terminal differentiation of cultured human keratinocytes. J Invest Dermatol
112:432±436, 1999
Shimizu A, Kato M, Nakao A, et al: Identi®cation of receptors and Smad proteins
38 BEER ET AL JID SYMPOSIUM PROCEEDINGS
involved in activin signalling in a human epidermal keratinocyte cell line. Genes
Cells 3:125±134, 1998
Staiano-Coico L, Krueger JG, Rubin JS, et al: Human keratinocyte growth factor
effects in a porcine model of epidermal wound healing. J Exp Med 178:865±
878, 1993
Sugiyama M, Ichida T, Sato T, Ishikawa T, Matsuda Y, Asakura H: Expression of
activin A is increased in cirrhotic and ®brotic rat livers. Gastroenterology
114:550±558, 1998
Vale W, Hsueh A, Rivier C, Yu J: The inhibin/activin family of hormones and
growth factors. In: Sporn MB, Roberts AB, eds. Peptide Growth Factors and
Their Receptors II, Berlin: Springer, 1990, pp. 211±248
Vassar R, Rosenberg M, Ross S, Tyner A, Fuchs E: Tissue-speci®c and
differentiation-speci®c expression of a human K14 keratin gene in transgenic
mice. Proc Natl Acad Sci USA 86:1563±1567, 1989
Werner S, Peters KG, Longaker MT, Fuller-Pace F, Banda M, Williams LT: Large
induction of keratinocyte growth factor expression in the dermis during wound
healing. Proc Natl Acad Sci USA 89:6896±6900, 1992
Werner S, Smola H, Liao X, Longaker MT, Krieg T, Hofschneider PH, Williams
LT: The function of KGF in epithelial morphogenesis and wound
reepithelialization. Science 266:819±822, 1994
Werner S: Keratinocyte growth factor: a unique player in epithelial repair processes.
Cytokine Growth Factor Rev 9:153±165, 1998
Yamasaki M, Miyake A, Tagashira S, Itoh N: Structure and expression of the rat
mRNA endoding a novel member of the ®broblast growth factor family. J Biol
Chem 271:15981±15921, 1996
VOL. 5, NO. 1 DECEMBER 2000 KGF AND ACTIVIN IN WOUND REPAIR 39
